# entry[].resource.text.div
International Patient Summary for Peter KEITH JORDAN

# entry[].resource.section[].code.coding[].display
Allergies and adverse reactions Document

# entry[].resource.section[].text.div
No known allergies or intolerances.

# entry[].resource.section[].text.div
Condition | Category | Recorded On | Clinical Status | Verification Status
Essential hypertension | Problem List Item | 2016-05-25 | active | confirmed
Gout | Problem List Item | 2020-10-01 | active | confirmed

# entry[].resource.section[].text.div
Drug | Status | Effective | Instructions
cilazapril 500 microgram tablet, 90 | Stopped | 2023-12-01 | Take 1 daily
lisinopril 5 mg tablet | Active | 2025-02-13 | Take One tablet once daily
Ultraproct - cinchocaine 0.5% (5 mg/g) + fluocortolone hexanoate 0.095% (945 microgram/g) + fluocortolone pivalate 0.092% (918 microgram/g) ointment | Active | 2024-08-30 | apply a small amount to the affected area up to 4 times daily on the first day, then twice daily for at least 1 week; continue for up to a maximum of 4 weeks

# entry[].resource.section[].text.div
Vaccine | Status | Occurance | Route | Dose # | Series
SARS-CoV-2 mRNA vaccine | Completed | 2025-04-01 | Injection, intramuscular | 6 | 6 (Booster or Extra dose)
Influenza vaccine | Completed | 2025-04-01 | Injection, intramuscular | 1 | 1 (Over 65 years (Influenza))
Influenza vaccine | Completed | 2024-04-10 | Injection, intramuscular | 1 | 1 (Over 65 years (Influenza))
SARS-CoV-2 mRNA vaccine | Completed | 2024-02-18 | Injection, intramuscular | 5 | 6 (Booster or Extra dose)
SARS-CoV-2 mRNA vaccine | Completed | 2022-08-01 | Injection, intramuscular | 4 | 12 (At risk, no previous history)
Human alphaherpesvirus 3 antigen-containing vaccine product | Completed | 2022-07-13 | Injection, intramuscular | 1 | 65Y (65 years)
SARS-CoV-2 mRNA vaccine | Completed | 2022-01-13 | Injection, intramuscular | 3 | 12 (At risk, no previous history)
SARS-CoV-2 mRNA vaccine | Completed | 2021-08-27 | Injection, intramuscular | 2 | 12 (At risk, no previous history)
SARS-CoV-2 mRNA vaccine | Completed | 2021-08-05 | Injection, intramuscular | 1 | 12 (At risk, no previous history)

# entry[].resource.section[].text.div
There is no information available about the subject's past history of procedures.

# entry[].resource.section[].text.div
Type | Result | Date
0055 (Uric Acid) | 0.41 mmol/L | 2024-08-30T08:56:00+00:00
1080 (Lipid Comments.) | A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia. | 2024-08-30T08:56:00+00:00
1080 (Cholesterol) | 5.5 mmol/L | 2024-08-30T08:56:00+00:00
1080 (LDL Chol - calculated) | 3.7 mmol/L | 2024-08-30T08:56:00+00:00
1080 (Total/HDL Chol Ratio) | 4.2 mmol/L | 2024-08-30T08:56:00+00:00
1080 (Triglyceride) | 1.3 mmol/L | 2024-08-30T08:56:00+00:00
1080 (HDL Cholesterol) | 1.32 mmol/L | 2024-08-30T08:56:00+00:00
3711 (Screening FIT) | Negative | 2024-03-12T00:00:00+00:00
0063 (HbA1c (IFCC)) | 35 mmol/mol | 2024-03-11T11:17:00+00:00
0055 (Uric Acid) | 0.41 mmol/L | 2024-03-11T11:17:00+00:00
0055 (Creatinine) | 88 umol/L | 2024-03-11T11:17:00+00:00
0055 (eGFR) | 78 mL/min | 2024-03-11T11:17:00+00:00
0055 (Potassium) | 4.7 mmol/L | 2024-03-11T11:17:00+00:00
0055 (Sodium) | 142 mmol/L | 2024-03-11T11:17:00+00:00
1540 (TSH) | 1.20 mU/L | 2024-03-11T11:17:00+00:00
1080 (Triglyceride) | 1.3 mmol/L | 2024-03-11T11:17:00+00:00
1080 (HDL Cholesterol) | 1.55 mmol/L | 2024-03-11T11:17:00+00:00
1080 (Total/HDL Chol Ratio) | 4.0 mmol/L | 2024-03-11T11:17:00+00:00
1080 (LDL Chol - calculated) | 4.1 mmol/L | 2024-03-11T11:17:00+00:00
1080 (Cholesterol) | 6.2 mmol/L | 2024-03-11T11:17:00+00:00
1080 (Lipid Comments.) | A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia. | 2024-03-11T11:17:00+00:00
0320 (Calcium (adjusted for Albumin)) | 2.49 mmol/L | 2024-03-11T11:17:00+00:00
0320 (Calcium) | 2.52 mmol/L | 2024-03-11T11:17:00+00:00
0320 (Phosphorus) | 1.30 mmol/L | 2024-03-11T11:17:00+00:00
1960 (Vitamin B12) | 212 pmol/L | 2024-03-11T11:17:00+00:00
1960 (Folate) | 22.4 nmol/L | 2024-03-11T11:17:00+00:00
4014 (Differential: Neut Seg) | 2.4 10*9/L | 2024-03-11T11:17:00+00:00
4014 (Differential: Monocyte) | 0.5 10*9/L | 2024-03-11T11:17:00+00:00
4014 (Differential: Basophil) | 0.1 10*9/L | 2024-03-11T11:17:00+00:00
4014 (PLATELET COUNT) | 207 10*9/L | 2024-03-11T11:17:00+00:00
4014 (Differential: Lymphocyte) | 1.5 10*9/L | 2024-03-11T11:17:00+00:00
4014 (MCV) | 92 fL | 2024-03-11T11:17:00+00:00
4014 (WBC) | 4.6 10*9/L | 2024-03-11T11:17:00+00:00
4014 (HAEMOGLOBIN) | 146 g/L | 2024-03-11T11:17:00+00:00
4014 (MCH) | 31 pg | 2024-03-11T11:17:00+00:00
4014 (HCT) | 0.44 L/L | 2024-03-11T11:17:00+00:00
4014 (Differential: Eosinophil) | 0.1 10*9/L | 2024-03-11T11:17:00+00:00
0100 (ALT) | 16 U/L | 2024-03-11T11:17:00+00:00
0100 (Bilirubin total) | 11 umol/L | 2024-03-11T11:17:00+00:00
0100 (GGT) | 20 U/L | 2024-03-11T11:17:00+00:00
0100 (Globulin) | 30 g/L | 2024-03-11T11:17:00+00:00
0100 (Alk Phosphatase) | 73 U/L | 2024-03-11T11:17:00+00:00
0100 (Total Protein) | 70 g/L | 2024-03-11T11:17:00+00:00
0100 (Albumin) | 40 g/L | 2024-03-11T11:17:00+00:00

# entry[].resource.section[].text.div
Type | Result | Date
Systolic blood pressure | 140 mmHg | 2024-08-30T08:32:00+00:00
Diastolic blood pressure | 80 mmHg | 2024-08-30T08:32:00+00:00

# entry[].resource.section[].text.div
Type | Result | Date
Tobacco smoking status | Never smoker | 2022-10-20
Alcoholic drinks per day | 1 d | 2016-06-22

# entry[].resource.section[].text.div
Shellfish free diet to prevent excess uric acid levels triggering gout attacks.

# entry[].resource.section[].code.coding[].display
Patient Goals, preferences, and priorities for care experience

# entry[].resource.section[].text.div
Patient undergoing lifestyle changes to lower blood pressure.

# entry[].resource.text.div
Name: Peter KEITH JORDAN

# entry[].resource.text.div
Name: NorthCare Thomas Road

# entry[].resource.text.div
Role: Doctor

# entry[].resource.text.div
Name: HASHIRA COORAY

# entry[].resource.text.div
No known allergy

# entry[].resource.text.div
Essential hypertension

# entry[].resource.text.div
Gout (disorder)

# entry[].resource.text.div
31099751000116106 (cilazapril 500 microgram tablet, 90)

# entry[].resource.text.div
10070691000116102 (lisinopril 5 mg tablet)

# entry[].resource.text.div
10717681000116108 (Ultraproct - cinchocaine 0.5% (5 mg/g) + fluocortolone hexanoate 0.095% (945 microgram/g) + fluocortolone pivalate 0.092% (918 microgram/g) ointment)

# entry[].resource.medicationCodeableConcept.text
Ultraproct - cinchocaine 0.5% (5 mg/g) + fluocortolone hexanoate 0.095% (945 microgram/g) + fluocortolone pivalate 0.092% (918 microgram/g) ointment

# entry[].resource.dosage[].text
apply a small amount to the affected area up to 4 times daily on the first day, then twice daily for at least 1 week; continue for up to a maximum of 4 weeks

# entry[].resource.text.div
217 (COVID-19 Comirnaty JN.1 30mcg)

# entry[].resource.text.div
99006 (Influenza)

# entry[].resource.text.div
99006 (Influenza)

# entry[].resource.text.div
300 (COVID-19 Comirnaty mRNA-CV Bivalent (15mcg/15mcg))

# entry[].resource.vaccineCode.text
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose

# entry[].resource.text.div
208 (Pfizer/BioNtech)

# entry[].resource.vaccineCode.text
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

# entry[].resource.text.div
121 (Zoster)

# entry[].resource.vaccineCode.coding[].display
Human alphaherpesvirus 3 antigen-containing vaccine product

# entry[].resource.vaccineCode.text
Live attenuated shingles vaccine, unspecified

# entry[].resource.text.div
208 (Pfizer/BioNtech)

# entry[].resource.vaccineCode.text
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

# entry[].resource.text.div
208 (Pfizer/BioNtech)

# entry[].resource.vaccineCode.text
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

# entry[].resource.text.div
208 (Pfizer/BioNtech)

# entry[].resource.vaccineCode.text
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

# entry[].resource.text.div
No known procedures

# entry[].resource.text.div
0063 (HBA1c)

# entry[].resource.text.div
0055 (GENERAL CHEM....)

# entry[].resource.text.div
0055 (GENERAL CHEM....)

# entry[].resource.text.div
1540 (TFTs............)

# entry[].resource.text.div
1080 (LIPIDS..........)

# entry[].resource.text.div
0320 (CALCIUM.........)

# entry[].resource.text.div
3711 (Screening FIT)

# entry[].resource.text.div
1080 (LIPIDS..........)

# entry[].resource.text.div
1960 (B12 and folate)

# entry[].resource.text.div
4014 (CBC)

# entry[].resource.text.div
0100 (Liver Function Tests)

# entry[].resource.text.div
0063 (HbA1c (IFCC))

# entry[].resource.note[].text
(<41)  If used as a screening test, diabetes is virtually

# entry[].resource.text.div
0055 (Uric Acid)

# entry[].resource.note[].text
The urate target level for gout management is <0.36 mmol/L

# entry[].resource.text.div
0055 (Creatinine)

# entry[].resource.text.div
0055 (eGFR)

# entry[].resource.text.div
0055 (Potassium)

# entry[].resource.text.div
0055 (Sodium)

# entry[].resource.text.div
0055 (Uric Acid)

# entry[].resource.note[].text
The urate target level for gout management is <0.36 mmol/L

# entry[].resource.text.div
1540 (TSH)

# entry[].resource.text.div
1080 (Triglyceride)

# entry[].resource.text.div
1080 (HDL Cholesterol)

# entry[].resource.text.div
1080 (Total/HDL Chol Ratio)

# entry[].resource.text.div
1080 (LDL Chol - calculated)

# entry[].resource.text.div
1080 (Cholesterol)

# entry[].resource.text.div
1080 (Lipid Comments.)

# entry[].resource.valueString
A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia.

# entry[].resource.text.div
0320 (Calcium (adjusted for Albumin))

# entry[].resource.text.div
0320 (Calcium)

# entry[].resource.text.div
0320 (Phosphorus)

# entry[].resource.text.div
3711 (Screening FIT)

# entry[].resource.note[].text
This is a result from the National Bowel Screening Programme.

# entry[].resource.text.div
1080 (Lipid Comments.)

# entry[].resource.valueString
A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia.

# entry[].resource.text.div
1080 (Cholesterol)

# entry[].resource.text.div
1080 (LDL Chol - calculated)

# entry[].resource.text.div
1080 (Total/HDL Chol Ratio)

# entry[].resource.text.div
1080 (Triglyceride)

# entry[].resource.text.div
1080 (HDL Cholesterol)

# entry[].resource.text.div
1960 (Vitamin B12)

# entry[].resource.text.div
1960 (Folate)

# entry[].resource.text.div
4014 (Differential: Neut Seg)

# entry[].resource.text.div
4014 (Differential: Monocyte)

# entry[].resource.text.div
4014 (Differential: Basophil)

# entry[].resource.text.div
4014 (PLATELET COUNT)

# entry[].resource.text.div
4014 (Differential: Lymphocyte)

# entry[].resource.text.div
4014 (MCV)

# entry[].resource.text.div
4014 (WBC)

# entry[].resource.text.div
4014 (HAEMOGLOBIN)

# entry[].resource.text.div
4014 (MCH)

# entry[].resource.text.div
4014 (HCT)

# entry[].resource.text.div
4014 (Differential: Eosinophil)

# entry[].resource.text.div
0100 (ALT)

# entry[].resource.text.div
0100 (Bilirubin total)

# entry[].resource.text.div
0100 (GGT)

# entry[].resource.text.div
0100 (Globulin)

# entry[].resource.text.div
0100 (Alk Phosphatase)

# entry[].resource.text.div
0100 (Total Protein)

# entry[].resource.text.div
0100 (Albumin)

# entry[].resource.text.div
Blood pressure panel with all children optional

# entry[].resource.code.coding[].display
Blood pressure panel with all children optional

# entry[].resource.text.div
Tobacco smoking status

# entry[].resource.text.div
Alcoholic drinks per day

# entry[].resource.text.div
Role: Clinical pathologist

# entry[].resource.text.div
Shellfish free diet.